A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma

Lung adenocarcinoma is one of the most malignant diseases worldwide. The immune checkpoint inhibitors targeting programmed cell death protein 1 (PD-1) and programmed cell death-ligand 1 (PD-L1) have changed the paradigm of lung cancer treatment; however, there are still patients who are resistant. F...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Cell Dev Biol
Main Authors: Zheng, Yujia, Tian, He, Zhou, Zheng, Xiao, Chu, Liu, Hengchang, Liu, Yu, Wang, Liyu, Fan, Tao, Zheng, Bo, Tan, Fengwei, Xue, Qi, Gao, Gengshu, Li, Chunxiang, He, Jie
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Cell and Developmental Biology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8017122/
https://ncbi.nlm.nih.gov/pubmed/33816503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2021.651406
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados